Navigation Links
ImaRx Postpones Release of First Quarter 2008 Financial Results
Date:5/13/2008

Live Webcast and Conference Call Scheduled for Thursday, May 15th at 5 PM

ET

TUCSON, Ariz., May 13 /PRNewswire-FirstCall/ -- ImaRx Therapeutics, Inc. (Nasdaq: IMRX) today announced that the Company has postponed its live webcast and conference call to Thursday, May 15, 2008, at 5:00 p.m. ET to discuss first quarter 2008 financial results; this call was originally scheduled for Tuesday, May 13, 2008, at 5:00 p.m. ET.

The live webcast can be accessed through ImaRx's corporate website at http://www.imarx.com and will be archived on the website for 14 days following the event.

Interested parties may access the conference call by dialing (877) 407-4018 in the U.S. and Canada or (201) 689-8471 internationally. A telephonic replay will be available through May 22, 2008 by dialing (877) 660-6853 in the U.S. and Canada or (201) 612-7415 internationally (Account Number 3055 and Conference ID 284385).

About ImaRx Therapeutics

ImaRx Therapeutics is a biopharmaceutical company developing and commercializing therapies for vascular disorders. The Company's research and development efforts are focused on therapies for stroke and other vascular disorders using its proprietary microbubble technology. The Company's commercialization efforts are currently focused on its product, urokinase, for the treatment of acute massive pulmonary embolism.

Contacts:

The Ruth Group (Investors/Media)

Sara Ephraim/Jason Rando

646-536-7002 or 7025

sephraim@theruthgroup.com

jrando@theruthgroup.com


'/>"/>
SOURCE ImaRx Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. ImaRx Schedules Release of First Quarter 2008 Financial Results
2. ImaRx Therapeutics Signs Letter of Intent With Microbix Biosystems for the Sale of Urokinase
3. ImaRx Therapeutics Satisfies Abbott Note Obligation Associated With the Acquisition of Urokinase
4. ImaRx Therapeutics Receives Notification from NASDAQ Regarding Non-Compliance with NASDAQs Minimum Bid Price Requirement
5. ImaRx Therapeutics Reports Business Update and Financial Results for Fourth Quarter and Full Year 2007
6. ImaRx Reschedules Release of Corporate Updates and Fourth Quarter and Full Year 2007 Financial Results
7. ImaRx to Report Corporate Updates and 4Q07 Financial Results
8. ImaRx Therapeutics Receives Urokinase Lot Release Approval With Extended Expiration Dating
9. Chem Rx Corporation Postpones Conference Call to Review Full Year 2007 Financial Results
10. BioTrends Releases Two Publications - TreatmentTrends(TM): Nephrologists and TreatmentTrends(TM): Renal Dietitians - Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism
11. Novavax Announces Release Date of 2008 First Quarter Financial Results and Investor Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2008)...hould Die of Diabetes, BRUSSELS, October 13 /PRNe...IDF) announced today that it is bringing together ...are for the thousands of children,with diabetes in...e meeting, Access to Essential Diabetes Medicines ... on Saturday, October 25 in London, United,Kingdom...
(Date:10/13/2008)...wswire-FirstCall/ -- Thursday and Friday of,last w...ic,s (NYSE: BSX ),stock. As anticipated in the Co...rtion of this trading was due to involuntary sales...,s co-founders Pete Nicholas and,John Abele. As of...31,million shares in aggregate had been sold last ...
(Date:10/13/2008)... /- WebLOQ, Inc., the emerging,leader...nt eBusiness and,data-in-motion communications, to...ployed the WebLOQ ePrivacy solution in their state...h their healthcare partner, the,Monterey Peninsula...plemented WebLOQ,s hosted, on demand ePrivacy tech...
(Date:10/13/2008)...ctober 13 /-,Following fulf...as now,completed the acquisition* of all outstandi... in prescription optical equipment., Satisloh des...surfacing,machines, as well as consumables, for pr...n in revenue in 2007 and employs more than 400 peo...
Breaking Biology Technology:International Diabetes Federation Calls for Global Action to Keep All Children With Diabetes Alive 2International Diabetes Federation Calls for Global Action to Keep All Children With Diabetes Alive 3Boston Scientific Provides Update on Involuntary Selling of Its Stock by Co-Founders 2Boston Scientific Provides Update on Involuntary Selling of Its Stock by Co-Founders 3Monterey Spine and Joint Deploys WebLOQ ePrivacy Solution for HIPAA Compliant Health Information Exchange 2Monterey Spine and Joint Deploys WebLOQ ePrivacy Solution for HIPAA Compliant Health Information Exchange 3
...rs Note: Wisconsins Department of Workforce Deve...gthening the states workforce. The department has ...bs, increase wages, address workforce shortages an...o Wisconsin workers. Secretary Roberta Gassman in ... talks about how DWD is investing in people and ho...
...EE-- ARI , a provider of business solutions that c...and distribution networks, announced today that Ha...t to license ARI,s EMPARTweb e-Catalog solution fo...okup and ordering service within their dealer webs...web, provide ongoing updates for selected manufact...
...eld, Wis.-- Fiserv Credit Processing Services se...t solutions to help ensure response time of its cr... Fiserv Credit Processing Services provides outso...s a unit of Fiserv, Inc. , ,Fiserv Credit Processi...enhances their ability to manage credit decisions,...
...s suggest 1500 Megawatts of Electricity Could Be S...e Wisconsin, especially after the California Energ... paradigm shift. There was a time when the major p...d with the utilities, the federal government and i...the environmental component of each decision made ...
Other Biology Technology:WTN Interview: Roberta Gassman 2WTN Interview: Roberta Gassman 3Wisconsins Businesses Can Become Environmental Leaders 2Wisconsins Businesses Can Become Environmental Leaders 3
(Date:10/12/2008)...built-in weapon against HIV, but until recently no... published online by the journal Nature reveals ...wn as APOBEC-3G and suggests new directions for d... human cell. It is capable of stopping HIV at the ...nscribes its RNA into viral DNA. , The study,s a...
(Date:10/10/2008)...formation technology have shaped not only how we f... medicines. A project just funded by the National ...drug design to the next level. , The University ...ance the molecular data needed to develop computer...rug candidates. The data will be housed in a Web-b...
(Date:10/10/2008)...om the Peninsula Medical School in Plymouth, UK, h...r of moderate exercise a day recommended to childr... the rising problem of childhood obesity. , Thei...ssue of the journal "Archives of Diseases in Child...dy, which has followed the development of over 200...
(Date:10/10/2008)...is available in German . , DNA, the molecule ... all forms of life, is highly resistant against al...he mechanism for its photostability presents some ... between the four chemical bases that make up the ...succeeded in showing that DNA strands differ in th...
Breaking Biology News(10 mins):Body's anti-HIV drug explained 2New data resource to advance computer-aided drug design 2Recommendations for children's exercise lacking say experts 2Can genetic information be controlled by light? 2Age alone should not be used to determine whether to treat prostate cancer with hormones 26740 1Age alone should not be used to determine whether to treat prostate cancer with hormones 26740 2Age alone should not be used to determine whether to treat prostate cancer with hormones 26740 3Lilly to Sponsor Congressional Black Caucus Foundations Annual Legislative Conference 26734 1Lilly to Sponsor Congressional Black Caucus Foundations Annual Legislative Conference 26734 2Lilly to Sponsor Congressional Black Caucus Foundations Annual Legislative Conference 26734 3LodgeNet Healthcare Signs New Agreement with NorthShore University HealthSystem 26729 1LodgeNet Healthcare Signs New Agreement with NorthShore University HealthSystem 26729 2LodgeNet Healthcare Signs New Agreement with NorthShore University HealthSystem 26729 3New Report on 633 Biotechnology Medicines Under Development Released in Michigan 7901 1New Report on 633 Biotechnology Medicines Under Development Released in Michigan 7901 2New Report on 633 Biotechnology Medicines Under Development Released in Michigan 7901 3
...elsh streams and rivers, affecting the number and ... Cardiff University study has found. , Rivers and...es and form important links with surrounding habit...the ecological effects of climate change on these ...y at Llyn Brianne in central Wales, led by Profess...
... mice from developing a brain disease similar to m... presented at the American Academy of Neurology,s ...07. Prion diseases, which include scrapie, mad cow...nd there is no treatment or cure. , The disease s... animals contaminated with prions. The disease cau...
...ule in the body appears to control whether certain...nists used in acute heart failure or in inhalers f...itric oxide is a molecule produced by the body tha...on or dilation of blood vessels. , New experime...d Howard Hughes Medical Institute researchers have...
...Fuel companies aren,t touting that slogan. At leas...y Bruce Dale, Michigan State University professor ...ing fuels from poplar trees and corn stalks is bec... is internationally known for his 30 years of rese...ms, leaves, stalks and trunks of plants and trees ...
Other Biology News:Vaccine prevents prion disease in mice 2Nitric oxide: Key to cardiovascular and pulmonary function and drug effectiveness 2Nitric oxide: Key to cardiovascular and pulmonary function and drug effectiveness 3
...ly Gradient thermal cycler which enables you to op... ,Wide linear gradient - The most linear gradient...C. Protocols can be optimised in a single experime...orates a large, 115 x 90mm, touch-sensitive screen...
... with a comprehensive array of accessories. JULAB...s, splash-water protected keypad offer a high oper...cating up to 6 temperature values is visible from ... with PID temperature control eliminates temperatu...
...abilizer is an aqueous solution that contains a pu...ing chemicals in a MOPS buffer (3-(N-Morpholino) p...ontains a combination of 0.02% methylisothiazolone...Rohm and Haas Company) as a preservative. StabilZ...
Request Info
Biology Products: